GRENOBLE, France, March 12, 2026 (GLOBE NEWSWIRE)-- Koelis, SAS (“Koelis” or the “Company”, www.koelis.com), a leader and innovator in MRI-ultrasound fusion guidance for prostate cancer interventions, ...
Clarity Pharmaceuticals recently announced that its pivotal Phase III AMPLIFY trial of 64Cu-SAR-bisPSMA PET for recurrent prostate cancer has fully consented more than the planned 220 participants ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results